The company said its sales for Q3 2026 were $4,994 million, up 1% as reported and 7% organically. Operating income was $740 million, up 79%. It said operating margin rose 640 basis points to 14.8%.

1. 01

   The company said its sales for Q3 2026 were $4,994 million, up 1% as reported and 7% organically. Operating income was $740 million, up 79%. It said operating margin rose 640 basis points to 14.8%.

2. 02

   The company said diluted earnings per share from continuing operations were $2.40, down 20%, and cited the one-time gain from the prior-year Resideo termination agreement as the main reason. It said adjusted EPS rose 34% to $2.27.

3. 03

   The company said operating cash flow from continuing operations for Q3 was $607 million, down 74%, and attributed the decline mainly to the one-time settlement from the prior-year Resideo termination agreement. It said free cash flow rose 15% to $688 million, with free cash flow conversion of 95%.

4. 04

   The company said it now expects full-year 2026 sales of $20.0 billion to $20.1 billion, versus its previous guidance of $19.8 billion to $20.0 billion, and adjusted EPS of $8.40 to $8.45, versus previous guidance of $8.05 to $8.35. It said free cash flow is now expected to be about $2.1 billion, up from about $2.0 billion.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.